The Pharmacy of the World: How Viatris Drives Competitors Out of the Market Through Sheer Mass
Reading Time: 4 minutes
Viatris utilizes massive cash flows from legendary brands like Viagra and a vast generic portfolio to reliably pay high dividends and reduce corporate debt. To escape the price pressure in the standard business, management is radically restructuring the company and focusing on high-growth niche markets like ophthalmology. For investors, the stock is currently a classic value stock that stands out due to its attractive valuation and dividends. Viatris (NASDAQ: VTRS) is not a typical pharmaceutical company searching for its fortune...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
